QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (825)	2/16/2000 9:39:00 PM
From: Julian	Read Replies (2) of 1321

TD Securities on Monday issued a report recommending REDUCE holdings in QLT based upon increased scrutiny of revenues as production ramps up and a weak inventory of products. 1 yr target price $65 also on monday this news was released QLT Photo. Reiterated 'Speculative Strong Buy' at Nesbitt Burns (February 14 , 11:01 am) QLT Phototherap. Reiterated 'Strong Buy' at Deutsche Banc AB (February 14 , 10:18 am) QLT Photo. Reiterated 'Strong Buy' at Yorkton Securities (February 14 , 10:10 am)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next